ASTROCYTOMA CELLS HARBORING MUTANT IDH1 ARE UNIQUELY SENSITIVE TO INHIBITION OF OXIDATIVE PHOSPHORYLATION

被引：0
|
作者：
Gurjar, Anagha [1 ]
Colman, Howard [2 ]
Holmen, Sheri [1 ]
机构：
[1] Univ Utah, Huntsman Inst, Hlth Sci Ctr, Salt Lake City, UT USA
[2] Univ Utah, Huntsman Canc Inst, Dept Neurosurg, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-69
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [21] Mutant IDH1 and thrombosis in gliomas
    Unruh, Dusten
    Schwarze, Steven R.
    Khoury, Laith
    Thomas, Cheddhi
    Wu, Meijing
    Chen, Li
    Chen, Rui
    Liu, Yinxing
    Schwartz, Margaret A.
    Amidei, Christina
    Kumthekar, Priya
    Benjamin, Carolina G.
    Song, Kristine
    Dawson, Caleb
    Rispoli, Joanne M.
    Fatterpekar, Girish
    Golfinos, John G.
    Kondziolka, Douglas
    Karajannis, Matthias
    Pacione, Donato
    Zagzag, David
    McIntyre, Thomas
    Snuderl, Matija
    Horbinski, Craig
    ACTA NEUROPATHOLOGICA, 2016, 132 (06) : 917 - 930
  • [22] A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres
    Alexandra Borodovsky
    Alan K. Meeker
    Ewen F. Kirkness
    Qi Zhao
    Charles G. Eberhart
    Gary L. Gallia
    Gregory J. Riggins
    Journal of Neuro-Oncology, 2015, 121 : 479 - 487
  • [23] A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres
    Borodovsky, Alexandra
    Meeker, Alan K.
    Kirkness, Ewen F.
    Zhao, Qi
    Eberhart, Charles G.
    Gallia, Gary L.
    Riggins, Gregory J.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (03) : 479 - 487
  • [24] Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
    Ruiz-Rodado, Victor
    Dowdy, Tyrone
    Lita, Adrian
    Kramp, Tamalee
    Zhang, Meili
    Shuboni-Mulligan, Dorela
    Herold-Mende, Christel
    Armstrong, Terri S.
    Gilbert, Mark R.
    Camphausen, Kevin
    Larion, Mioara
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Wild-type IDH1: A molecular target in IDH1 mutant cancers
    Wickenden, Julie A.
    Russell, Paul
    Smith, Amy
    Henley, Tom
    Elliott, Jane
    Gitterman, Dan
    Stockdale, Mark
    Schofield, Christine
    Torrance, Chris
    Moore, Jonathan D.
    CANCER RESEARCH, 2014, 74 (19)
  • [26] In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2
    Rana Gbyli
    Yuanbin Song
    Wei Liu
    Yimeng Gao
    Giulia Biancon
    Namrata S. Chandhok
    Xiaman Wang
    Xiaoying Fu
    Amisha Patel
    Ranjini Sundaram
    Toma Tebaldi
    Padmavathi Mamillapalli
    Amer M. Zeidan
    Richard A. Flavell
    Thomas Prebet
    Ranjit S. Bindra
    Stephanie Halene
    Leukemia, 2022, 36 : 1313 - 1323
  • [27] In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2
    Gbyli, Rana
    Song, Yuanbin
    Liu, Wei
    Gao, Yimeng
    Biancon, Giulia
    Chandhok, Namrata S.
    Wang, Xiaman
    Fu, Xiaoying
    Patel, Amisha
    Sundaram, Ranjini
    Tebaldi, Toma
    Mamillapalli, Padmavathi
    Zeidan, Amer M.
    Flavell, Richard A.
    Prebet, Thomas
    Bindra, Ranjit S.
    Halene, Stephanie
    LEUKEMIA, 2022, 36 (05) : 1313 - 1323
  • [28] IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors
    Molenaar, Remco J.
    Radivoyevitch, Tomas
    Nagata, Yasunobu
    Khurshed, Mohammed
    Przychodzen, Bartolomiej
    Makishima, Hideki
    Xu, Mingjiang
    Bleeker, Fonnet E.
    Wilmink, Johanna W.
    Carraway, Hetty E.
    Mukherjee, Sudipto
    Sekeres, Mikkael A.
    van Noorden, Cornelis J. F.
    Maciejewski, Jaroslaw P.
    CLINICAL CANCER RESEARCH, 2018, 24 (07) : 1705 - 1715
  • [29] Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
    Gupta, Charu
    Kaulfuss, Stefan
    Goerlich, Kerstin
    Othman, Basem
    Chaturvedi, Anuhar
    Heuser, Michael
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1415 - 1417
  • [30] PLK1 INHIBITION ENHANCES TEMOZOLOMIDE EFFICACY IN IDH1 MUTANT GLIOMAS
    Bahassi, El Mustapha
    Koncar, Robert
    Chu, Zhengtao
    Qi, Chiaoyang
    Romick-Rosendale, Lindsey
    Wells, Susanne
    Chan, Timothy
    NEURO-ONCOLOGY, 2016, 18 : 68 - 68
12345